Global HEOR Director - Value & Payer Strategy

Jazz Pharmaceuticals, Inc.; United States; Remote; USD 212,000 - 318,000; Full time

Benefits offered by this job

Medical insurance

Dental insurance

Vision insurance

401k retirement savings plan

Flexible paid vacation

Job summary

Jazz Pharmaceuticals is seeking a Director, Global Value and HEOR to lead global payer evidence strategy for pipeline assets from early development through global launch, with a US pre-launch HEOR lead remit and close collaboration with Clinical Development, Market Access, and EU/INT HEOR teams.

The role demands mastery of health economic modeling (CEA, BIM, Markov), experience with US AMCP PIE dossiers, HTA readiness, and rare-disease evidentiary approaches, plus strong leadership across

Qualifications

• Health economic modeling mastery with complex techniques.
• Experience shaping Phase 2/3 trial design for HTA readiness.
• Leadership in US pre-launch HEOR and AMCP PIE dossiers.
• Proven ability to deliver global launch assets (GVDs, ITCs/NMAs).
• Strong collaboration with regional HEOR teams (EU/INT).

Responsibilities

• Lead global payer evidence strategy for pipeline assets.
• Direct US pre-launch HEOR, payer tools, and dossiers.
• Develop early economic models and real-world evidence plans.
• Coordinate with EU/INT HEOR teams on HTA evidence strategy.
• Oversee launch readiness workstreams and evidence assets.

Skills

Health economic modeling mastery

Pipeline & trial interface experience

Dual global & US pre-launch acumen

Launch preparation excellence

Rare disease / orphan drug access

Cross-functional matrix leadership

Communication & scientific track

Education

Master’s degree in Health Economics or related field

Job description

Jazz Pharmaceuticals is seeking a Director, Global Value and HEOR to lead global payer evidence strategy for pipeline assets from early development through global launch, with a US pre-launch HEOR lead remit and close collaboration with Clinical Development, Market Access, and EU/INT HEOR teams.

The role demands mastery of health economic modeling (CEA, BIM, Markov), experience with US AMCP PIE dossiers, HTA readiness, and rare-disease evidentiary approaches, plus strong leadership across